Rochester Medical Corp. (ROCM) Posts Q3 adj.-EPS of $0.03, Tops by 4c
Rochester Medical Corp. (Nasdaq: ROCM) reports Q3 adjusted EPS of $0.03, 4 cents better than the analyst estimate of ($0.01). Revenue for the quarter was $10.24 million, which compares to the estimate of $9.86 million.
Get Alerted When News Hits On This Stock - FREE!